Kubilay Karsidag
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kubilay Karsidag has a total of 101 co-authors. Here are the top co-authors by number of shared publications:
- Ayse Kubat Uzum
Department of Internal Medicine, Division of Endocrinology and Metabolism, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
6 shared publications - Hulya Hacisahinogullari
Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Endocrinology and Metabolism, Istanbul, Turkiye
6 shared publications - Ozlem Soyluk Selcukbiricik
Istanbul University School of Medicine, Department of Endocrinology and Metabolism, Istanbul, Türkiye
6 shared publications - Ilhan Satman
Division of Endocrinology and Metabolism, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkiye
5 shared publications - Nurdan Gul
Division of Endocrinology and Metabolism, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkiye
4 shared publications - Ummu Mutlu
Istanbul University, Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Endocrinology and Metabolism, Istanbul, Turkiye
4 shared publications
Latest Publications
- 14 August 2026
- Published by Istanbul University in İstanbul Tıp Fakültesi Dergisi
- Vol. 89 (3) , 211-216
ASSOCIATION OF DIETARY INFLAMMATORY INDEX WITH SYSTEMIC INFLAMMATION IN WELL-CONTROLLED TYPE 2 DIABETES MELLITUS
Bjective: Low-grade chronic inflammation contributes to residual cardiometabolic risk in type 2 diabetes (T2DM), even among patients who achieve glycemic targets. Dietary Inflammatory Index (DII) quantifies the inflammatory potential of habitual diet; however, its association with systemic inflammatory markers in well-controlled T2DM remains unclear. This study aimed to investigate the association between DII scores and circulating inflammatory markers in adults with well-controlled T2DM.Material and Methods: This cross-sectional study included 120 adults with T2DM and 30 healthy controls. Dietary intake was assessed using a validated 7-day food frequency questionnaire, and DII scores were calculated. Patients with T2DM were stratified into DII quartiles. Serum levels of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and high-sensitive C-reactive protein (hs-CRP), along with metabolic parameters, were measured. Associations were evaluated using correlation and regression analyses, and effect sizes were estimated using Cohen’s d.Results: DII scores were positively correlated with IL-6 (r=0.421, p<0.001) and hs–CRP (r=0.312, p=0.002). IL 6 levels increased progressively across DII quartiles (p for trend <0.001), with a large effect size between the lowest and highest quartiles (Cohen’s d=0.84). Higher DII scores were associated with lower intakes of dietary fiber, polyunsaturated fatty acids, magnesium, and vitamin C (all p<0.05). Serum uric acid levels also increased across DII quartiles (p=0.044). No significant association was observed between DII and TNF-α.Conclusions: In adults with well-controlled T2DM, a more proinflammatory diet is associated with higher systemic inflammation, particularly elevated IL 6 levels. These findings suggest that dietary inflammatory potential may contribute to residual cardiometabolic risk beyond glycemic control.
- 14 August 2026
- Published by Istanbul University in İstanbul Tıp Fakültesi Dergisi
- Vol. 89 (3) , 211-216
ASSOCIATION OF DIETARY INFLAMMATORY INDEX WITH SYSTEMIC INFLAMMATION IN WELL-CONTROLLED TYPE 2 DIABETES MELLITUS
Bjective: Low-grade chronic inflammation contributes to residual cardiometabolic risk in type 2 diabetes (T2DM), even among patients who achieve glycemic targets. Dietary Inflammatory Index (DII) quantifies the inflammatory potential of habitual diet; however, its association with systemic inflammatory markers in well-controlled T2DM remains unclear. This study aimed to investigate the association between DII scores and circulating inflammatory markers in adults with well-controlled T2DM.Material and Methods: This cross-sectional study included 120 adults with T2DM and 30 healthy controls. Dietary intake was assessed using a validated 7-day food frequency questionnaire, and DII scores were calculated. Patients with T2DM were stratified into DII quartiles. Serum levels of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and high-sensitive C-reactive protein (hs-CRP), along with metabolic parameters, were measured. Associations were evaluated using correlation and regression analyses, and effect sizes were estimated using Cohen’s d.Results: DII scores were positively correlated with IL-6 (r=0.421, p<0.001) and hs–CRP (r=0.312, p=0.002). IL 6 levels increased progressively across DII quartiles (p for trend <0.001), with a large effect size between the lowest and highest quartiles (Cohen’s d=0.84). Higher DII scores were associated with lower intakes of dietary fiber, polyunsaturated fatty acids, magnesium, and vitamin C (all p<0.05). Serum uric acid levels also increased across DII quartiles (p=0.044). No significant association was observed between DII and TNF-α.Conclusions: In adults with well-controlled T2DM, a more proinflammatory diet is associated with higher systemic inflammation, particularly elevated IL 6 levels. These findings suggest that dietary inflammatory potential may contribute to residual cardiometabolic risk beyond glycemic control.
- Open Access
- 1 July 2026
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 18 (2) , 224-232
Type 1 Diabetes Mellitus and Transfer from Pediatric to Adult Care: A Single-Center Experience
Undefined - Journal of Clinical Research in Pediatric Endocrinology
- 1 July 2026
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 18 (2) , 224-232
Open AccessType 1 Diabetes Mellitus and Transfer from Pediatric to Adult Care: A Single-Center Experience
Undefined - Journal of Clinical Research in Pediatric Endocrinology
- Open Access
- 12 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1)
Multidimensional assessment of large language model responses to patient questions on gestational diabetes mellitus
Gestational diabetes mellitus (GDM) is a prevalent condition requiring accurate patient education, yet the reliability and readability of large language models (LLMs) in this context remain uncertain. This study evaluated the performance of four LLMs—ChatGPT-4o, Gemini 2.5 Pro, Grok 3.0, and DeepSeek R-1—using 25 patient-oriented questions derived from clinical scenarios. Seven endocrinologists independently rated the responses with the modified DISCERN (mDISCERN) instrument and the Global Quality Score (GQS). Readability was analyzed using the Flesch Reading Ease (FRES), Flesch–Kincaid Grade Level (FKGL), Gunning Fog Index (GFI), Coleman–Liau Index (CLI), and Simple Measure of Gobbledygook (SMOG), while lexical diversity was assessed through type–token ratio (TTR). Grok and Gemini obtained the highest mDISCERN and GQS scores, whereas ChatGPT performed significantly lower (p < 0.05). DeepSeek generated the most readable outputs, while Grok provided the longest and most complex responses. All models scored below the FRES threshold of 60 recommended for lay audiences. Response length showed strong positive correlations with mDISCERN and GQS, while TTR was inversely related to quality but positively associated with readability. These findings highlight variability among LLMs in GDM education and emphasize the need for model-specific improvements to ensure reliable patient-facing health information.
- 12 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1)
Open AccessMultidimensional assessment of large language model responses to patient questions on gestational diabetes mellitus
Gestational diabetes mellitus (GDM) is a prevalent condition requiring accurate patient education, yet the reliability and readability of large language models (LLMs) in this context remain uncertain. This study evaluated the performance of four LLMs—ChatGPT-4o, Gemini 2.5 Pro, Grok 3.0, and DeepSeek R-1—using 25 patient-oriented questions derived from clinical scenarios. Seven endocrinologists independently rated the responses with the modified DISCERN (mDISCERN) instrument and the Global Quality Score (GQS). Readability was analyzed using the Flesch Reading Ease (FRES), Flesch–Kincaid Grade Level (FKGL), Gunning Fog Index (GFI), Coleman–Liau Index (CLI), and Simple Measure of Gobbledygook (SMOG), while lexical diversity was assessed through type–token ratio (TTR). Grok and Gemini obtained the highest mDISCERN and GQS scores, whereas ChatGPT performed significantly lower (p < 0.05). DeepSeek generated the most readable outputs, while Grok provided the longest and most complex responses. All models scored below the FRES threshold of 60 recommended for lay audiences. Response length showed strong positive correlations with mDISCERN and GQS, while TTR was inversely related to quality but positively associated with readability. These findings highlight variability among LLMs in GDM education and emphasize the need for model-specific improvements to ensure reliable patient-facing health information.
- 25 November 2025
- Published by Elsevier in Primary Care Diabetes
- Vol. 20 (1) , 36-46
Efficacy of synchronized diabetes monitoring system in patients with type 2 diabetes: Preliminary results of a pilot, randomized clinical trial
- 25 November 2025
- Published by Elsevier in Primary Care Diabetes
- Vol. 20 (1) , 36-46
Efficacy of synchronized diabetes monitoring system in patients with type 2 diabetes: Preliminary results of a pilot, randomized clinical trial
- Open Access
Higher Prevalence of Thyroid Dysfunction in Type 2 Diabetes Mellitus: Effects on Glycemic Control, Diabetic Complications and Comorbidities
Background and Objectives: Thyroid dysfunction (TD) is more frequently observed in patients with diabetes mellitus (DM) compared to the general population. This study aims to determine the prevalence of TD in a large cohort of patients diagnosed with type 2 diabetes mellitus (T2DM) and to evaluate its possible impact on glycemic control, comorbidities, and diabetes-related complications. Materials and Methods: A total of 723 patients with type 2 diabetes mellitus (47.9% female, 52.1% male) were retrospectively evaluated. Demographic information of the patients, comprehensive history including onset and duration of DM and also comorbid diseases, diabetes-related complications, laboratory results, antidiabetic drugs and presence of TD were recorded and analyzed. Results: The prevalence of TD was 21.4% in 723 patients. Dyslipidemia was the most common comorbidity (63.6%). Patients with TD had significantly higher baseline BMI and longer diabetes duration (p = 0.007 and p = 0.048, respectively). Overall complication and comorbidity rates were 80.1% and 66%. TD was more common in females (73.4% vs. 26.6%; p < 0.001). Hypertension (69.5% vs. 58.7%) and neuropathy (40.9% vs. 33.0%) were significantly more frequent in the TD group (p < 0.05 for both). The total comorbidity rate was also higher in TD-positive patients (72.7% vs. 64.1%; p = 0.046). A significant positive correlation was observed between BMI and TSH levels. Conclusions: The increased prevalence of TD in patients with T2DM was clearly demonstrated. Female gender was identified as an independent risk factor, while elevated BMI and longer diabetes duration showed significant associations with TD status. The coexistence of TD and T2DM may contribute to a higher risk of diabetic complications and comorbidities. Routine screening of thyroid function is recommended to enable early identification and improve the overall clinical management.
Open AccessHigher Prevalence of Thyroid Dysfunction in Type 2 Diabetes Mellitus: Effects on Glycemic Control, Diabetic Complications and Comorbidities
Background and Objectives: Thyroid dysfunction (TD) is more frequently observed in patients with diabetes mellitus (DM) compared to the general population. This study aims to determine the prevalence of TD in a large cohort of patients diagnosed with type 2 diabetes mellitus (T2DM) and to evaluate its possible impact on glycemic control, comorbidities, and diabetes-related complications. Materials and Methods: A total of 723 patients with type 2 diabetes mellitus (47.9% female, 52.1% male) were retrospectively evaluated. Demographic information of the patients, comprehensive history including onset and duration of DM and also comorbid diseases, diabetes-related complications, laboratory results, antidiabetic drugs and presence of TD were recorded and analyzed. Results: The prevalence of TD was 21.4% in 723 patients. Dyslipidemia was the most common comorbidity (63.6%). Patients with TD had significantly higher baseline BMI and longer diabetes duration (p = 0.007 and p = 0.048, respectively). Overall complication and comorbidity rates were 80.1% and 66%. TD was more common in females (73.4% vs. 26.6%; p < 0.001). Hypertension (69.5% vs. 58.7%) and neuropathy (40.9% vs. 33.0%) were significantly more frequent in the TD group (p < 0.05 for both). The total comorbidity rate was also higher in TD-positive patients (72.7% vs. 64.1%; p = 0.046). A significant positive correlation was observed between BMI and TSH levels. Conclusions: The increased prevalence of TD in patients with T2DM was clearly demonstrated. Female gender was identified as an independent risk factor, while elevated BMI and longer diabetes duration showed significant associations with TD status. The coexistence of TD and T2DM may contribute to a higher risk of diabetic complications and comorbidities. Routine screening of thyroid function is recommended to enable early identification and improve the overall clinical management.
- 4 August 2025
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 121 (6) , 1445-1454
Ultraprocessed Grains and Risk of Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology Study
INTRODUCTION: Ultraprocessed grains, commonly consumed in Western diets, undergo refining processes that often remove beneficial components and include additives to enhance taste, texture, or durability, potentially influencing gastrointestinal health. This study examines the association between ultraprocessed grain consumption and the risk of developing inflammatory bowel disease (IBD) using data from the Prospective Urban Rural Epidemiology (PURE) study. METHODS: This analysis included 124,590 participants from 21 countries who had dietary data available in the PURE study. Dietary intake was assessed through validated food frequency questionnaires, and ultraprocessed grain intake was categorized into 3 levels. The primary outcome was the development of IBD, including Crohn's disease (CD) and ulcerative colitis (UC). Multivariate Cox proportional hazard models were used to calculate hazard ratios (HRs), adjusting for confounders including age, sex, smoking status, eating habits, and physical activity. RESULTS: Among 124,590 participants, higher ultraprocessed grain intake was associated with increased IBD risk. Participants consuming ≥19 g/d of ultraprocessed grains had a higher risk of developing IBD compared with those consuming P trend = 0.0003) after multivariate adjustment. Fresh bread and rice consumption were associated with lower IBD risk. Participants with greater ultraprocessed food intake (≥5 servings per day) were linked to a higher risk of developing IBD compared with those consuming P trend < 0.0001). DISCUSSION: Higher intake of ultraprocessed grains is associated with significantly increased risk of developing IBD. A healthy eating pattern should minimize consumption of ultraprocessed grains. Further studies should be performed to understand which components of ultraprocessed grains may be detrimental for health.
- 4 August 2025
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 121 (6) , 1445-1454
Ultraprocessed Grains and Risk of Inflammatory Bowel Disease: Results From the Prospective Urban Rural Epidemiology Study
INTRODUCTION: Ultraprocessed grains, commonly consumed in Western diets, undergo refining processes that often remove beneficial components and include additives to enhance taste, texture, or durability, potentially influencing gastrointestinal health. This study examines the association between ultraprocessed grain consumption and the risk of developing inflammatory bowel disease (IBD) using data from the Prospective Urban Rural Epidemiology (PURE) study. METHODS: This analysis included 124,590 participants from 21 countries who had dietary data available in the PURE study. Dietary intake was assessed through validated food frequency questionnaires, and ultraprocessed grain intake was categorized into 3 levels. The primary outcome was the development of IBD, including Crohn's disease (CD) and ulcerative colitis (UC). Multivariate Cox proportional hazard models were used to calculate hazard ratios (HRs), adjusting for confounders including age, sex, smoking status, eating habits, and physical activity. RESULTS: Among 124,590 participants, higher ultraprocessed grain intake was associated with increased IBD risk. Participants consuming ≥19 g/d of ultraprocessed grains had a higher risk of developing IBD compared with those consuming P trend = 0.0003) after multivariate adjustment. Fresh bread and rice consumption were associated with lower IBD risk. Participants with greater ultraprocessed food intake (≥5 servings per day) were linked to a higher risk of developing IBD compared with those consuming P trend < 0.0001). DISCUSSION: Higher intake of ultraprocessed grains is associated with significantly increased risk of developing IBD. A healthy eating pattern should minimize consumption of ultraprocessed grains. Further studies should be performed to understand which components of ultraprocessed grains may be detrimental for health.
- Open Access
- 1 January 2025
- Published by Wiley in Journal of Diabetes Research
- Vol. 2025 (1) , 8860118
Clinical Characteristics and Development of Complications Differ Between Adult‐Onset and Child–Adolescent‐Onset Type 1 Diabetes: A Report From a Tertiary Medical Center in Türkiye
Background and Aims: The age‐at‐onset is of great importance in the heterogeneity of Type 1 diabetes mellitus (T1DM). This study was designed to define clinical and laboratory differences between child–adolescent‐onset and adult‐onset T1DM at presentation and during follow‐up and determine the predicting factors for developing microvascular and macrovascular complications. Material and Methods: This retrospective observational study evaluated T1DM patients who were followed in the diabetes outpatient clinic between January 1, 2000, and December 31, 2019. Results: The study cohort included 490 individuals with T1DM (54.3% female, 58.8% adult‐onset, and median follow‐up: 5 years). In the adult‐onset group, baseline C‐peptide and GADA prevalence were higher, whereas presentation with ketoacidosis was 2.3‐fold lower compared to the child–adolescent‐onset group ( p < 0.001). During follow‐up, the adult‐onset group had a 2.4‐fold higher overweight/obesity ( p < 0.001) and 1.7‐fold higher dyslipidemia/hyperlipidemia ( p = 0.002) than the child–adolescent‐onset group. In multivariate analysis, fasting glucose ( p = 0.024) in adult‐onset, dyslipidemia/hyperlipidemia ( p = 0.037) in child–adolescent‐onset, and diabetes duration ( p = 0.008 and p = 0.007) and hypertension ( p = 0.001 and p = 0.01) in both groups were associated with increased risk of microvascular complications, whereas age‐at‐onset ( p = 0.024), dyslipidemia/hyperlipidemia ( p = 0.03), nephropathy ( p = 0.003), and neuropathy ( p = 0.001) in adult‐onset and age ( p = 0.002) and triglycerides ( p = 0.013) in child–adolescent‐onset groups were associated with increased risk of macrovascular complications. The cutoff C‐peptide levels at baseline predicted microvascular complications in the whole cohort and adult‐onset group were defined as 0.383 ng/mL ( p < 0.001) and 0.41 ng/mL ( p = 0.001), respectively. In the Kaplan–Meier analysis, C‐peptide (< 0.383 ng/mL) but not age‐at‐onset predicted future development of microvascular and macrovascular complications ( p = 0.003 and p = 0.032). Conclusion: Clinical presentation and prognosis differ in adult‐onset and child–adolescent‐onset T1DM. Low initial C‐peptide may predict the development of microvascular and macrovascular complications.
- 1 January 2025
- Published by Wiley in Journal of Diabetes Research
- Vol. 2025 (1) , 8860118
Open AccessClinical Characteristics and Development of Complications Differ Between Adult‐Onset and Child–Adolescent‐Onset Type 1 Diabetes: A Report From a Tertiary Medical Center in Türkiye
Background and Aims: The age‐at‐onset is of great importance in the heterogeneity of Type 1 diabetes mellitus (T1DM). This study was designed to define clinical and laboratory differences between child–adolescent‐onset and adult‐onset T1DM at presentation and during follow‐up and determine the predicting factors for developing microvascular and macrovascular complications. Material and Methods: This retrospective observational study evaluated T1DM patients who were followed in the diabetes outpatient clinic between January 1, 2000, and December 31, 2019. Results: The study cohort included 490 individuals with T1DM (54.3% female, 58.8% adult‐onset, and median follow‐up: 5 years). In the adult‐onset group, baseline C‐peptide and GADA prevalence were higher, whereas presentation with ketoacidosis was 2.3‐fold lower compared to the child–adolescent‐onset group ( p < 0.001). During follow‐up, the adult‐onset group had a 2.4‐fold higher overweight/obesity ( p < 0.001) and 1.7‐fold higher dyslipidemia/hyperlipidemia ( p = 0.002) than the child–adolescent‐onset group. In multivariate analysis, fasting glucose ( p = 0.024) in adult‐onset, dyslipidemia/hyperlipidemia ( p = 0.037) in child–adolescent‐onset, and diabetes duration ( p = 0.008 and p = 0.007) and hypertension ( p = 0.001 and p = 0.01) in both groups were associated with increased risk of microvascular complications, whereas age‐at‐onset ( p = 0.024), dyslipidemia/hyperlipidemia ( p = 0.03), nephropathy ( p = 0.003), and neuropathy ( p = 0.001) in adult‐onset and age ( p = 0.002) and triglycerides ( p = 0.013) in child–adolescent‐onset groups were associated with increased risk of macrovascular complications. The cutoff C‐peptide levels at baseline predicted microvascular complications in the whole cohort and adult‐onset group were defined as 0.383 ng/mL ( p < 0.001) and 0.41 ng/mL ( p = 0.001), respectively. In the Kaplan–Meier analysis, C‐peptide (< 0.383 ng/mL) but not age‐at‐onset predicted future development of microvascular and macrovascular complications ( p = 0.003 and p = 0.032). Conclusion: Clinical presentation and prognosis differ in adult‐onset and child–adolescent‐onset T1DM. Low initial C‐peptide may predict the development of microvascular and macrovascular complications.
- 1 March 2024
- Published by Galenos Yayinevi in Medical Journal of Bakırkoy
- Vol. 20 (1) , 7-14
Personalized Treatment Selection and Its Effects on Glycemic Control in Older Adults with Diabetes: A Single Center Experience
- 1 March 2024
- Published by Galenos Yayinevi in Medical Journal of Bakırkoy
- Vol. 20 (1) , 7-14
Personalized Treatment Selection and Its Effects on Glycemic Control in Older Adults with Diabetes: A Single Center Experience
- Open Access
- 4 September 2023
- Published by Springer Nature in Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity
- Vol. 28 (1) , 1-8
Psychometric properties and factor structure of the diabetes eatıng problem survey- revised (DEPS-R) among adults with type 1 diabetes mellitus
Background and objective: Although many studies on the Diabetes Eating Problem Survey–Revised (DEPS-R) in adolescents with type 1 diabetes mellitus (T1D), the number of studies validating this questionnaire in adults with T1D is limited. Therefore, this study aimed to examine the factor structure of the Turkish version of the DEPS-R in adults with T1D and internal consistency and construct validity. Methods: A total of 100 patients with T1D, ages 18–50 years, completed the DEPS-R and EDE-Q. In addition to tests of validity, confirmatory factor analysis was conducted to investigate the factor structure of the 6-item Turkish version of DEPS-R. Results: The Cronbach’s alpha coefficient of the DEPS-R Turkish version was 0.77, suggesting good internal consistency. The median (IQ) DEPS-R score was 15.0 (13.0) among all participants. DEPS-R score was significantly correlated with BMI (r = 0.210; p < 0.05) and EDE-Q (r = 0.586; p < 0.01). There was no correlation between the HbA1c values of participants and neither EDE-Q nor DEPS-R scores. The confirmatory factor analysis results show that the three-factor model was a good fit. Conclusion: A short, self-administered diabetes-specific screening tool for disordered eating behavior is recommended be used routinely in the clinical care of adults with T1D, and Turkish version of DEPS-R has acceptable internal consistency and construct validity in adults with T1D. Level of evidence: Level V, descriptive study. Clinicaltrials.gov registration number NCT05346679/ 21.04.2022 (retrospectively registered)
- 4 September 2023
- Published by Springer Nature in Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity
- Vol. 28 (1) , 1-8
Open AccessPsychometric properties and factor structure of the diabetes eatıng problem survey- revised (DEPS-R) among adults with type 1 diabetes mellitus
Background and objective: Although many studies on the Diabetes Eating Problem Survey–Revised (DEPS-R) in adolescents with type 1 diabetes mellitus (T1D), the number of studies validating this questionnaire in adults with T1D is limited. Therefore, this study aimed to examine the factor structure of the Turkish version of the DEPS-R in adults with T1D and internal consistency and construct validity. Methods: A total of 100 patients with T1D, ages 18–50 years, completed the DEPS-R and EDE-Q. In addition to tests of validity, confirmatory factor analysis was conducted to investigate the factor structure of the 6-item Turkish version of DEPS-R. Results: The Cronbach’s alpha coefficient of the DEPS-R Turkish version was 0.77, suggesting good internal consistency. The median (IQ) DEPS-R score was 15.0 (13.0) among all participants. DEPS-R score was significantly correlated with BMI (r = 0.210; p < 0.05) and EDE-Q (r = 0.586; p < 0.01). There was no correlation between the HbA1c values of participants and neither EDE-Q nor DEPS-R scores. The confirmatory factor analysis results show that the three-factor model was a good fit. Conclusion: A short, self-administered diabetes-specific screening tool for disordered eating behavior is recommended be used routinely in the clinical care of adults with T1D, and Turkish version of DEPS-R has acceptable internal consistency and construct validity in adults with T1D. Level of evidence: Level V, descriptive study. Clinicaltrials.gov registration number NCT05346679/ 21.04.2022 (retrospectively registered)